DANONE: Lack of clarity on the growth path | NEUTRAL | EUR76 vs. EUR71 (+6%)
DANONE - NEUTRAL | EUR76 vs. EUR71 (+6%)Lack of clarity on the growth path
Miss due to EDP and Waters
EDP: penalized by North America and Russia
Waters: negative impact from Mizone and comps in Europe
Specialized Nutrition: recovery helped by technical factors
Uncertainties about the extent of the recovery in Q4
2020 guidance: hardly achievable – Neutral maintained
Danone is engaged in activities in the global food and beverages industry. Co. operates in four markets: Fresh Dairy Products (Co. produces and sells yogurts, fermented dairy products and other fresh dairy products); Waters (Co. produces and sells natural waters as well as flavored and vitamin-enriched waters products); Early Life Nutrition (Co. produces baby formula, milk-and fruit-based desserts, cereals, small pots of baby food and ready-made baby food); and Medical Nutrition (Co. develops adult and pediatric clinical nutrition products to be taken orally, or through a catheter in the event of malnutrition related to illness or other causes).
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.